Σύγκριση μεθόδων

	Ερωτηματολόγιο Επίδρασης Κεφαλαλγίας-6 (HIT-6)	ΕΟΚΕ ΠΟΙΟΤΗΤΑ ΖΩΗΣ-C30
Πεδίο	Εκβάσεις Υγείας	Εκβάσεις Υγείας
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	2003	1993
Δημιουργός	Mark Kosinski et al.	Nico Aaronson et al.
Τύπος	Self-report functional impact questionnaire	Self-report quality of life questionnaire
Θεμελιώδης πηγή	Kosinski, M., Bayliss, M. S., Bjorner, J. B., Ware, J. E., Garber, W. H., Batenhorst, A., & Tepper, S. (2003). A six-item short-form survey for measuring headache impact: The HIT-6. Quality of Life Research, 12(8), 963-974.	Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376.
Εναλλακτικές ονομασίες	HIT-6, Headache Impact Test, HIT	QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale
Συναφείς	4	5
Σύνοψη	The HIT-6 is a brief, validated measure of headache impact on daily functioning and quality of life. Developed by Mark Kosinski and colleagues in 2003, this 6-item questionnaire quantifies how headache (migraine or other types) affects work, social activities, sleep, and emotional well-being. It is widely used in headache research, clinical trials, and practice to assess disease burden and treatment benefit.	The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.